Zimmer Biomet Holdings (ZBH) : Investors lapped up stocks on upticks to the tune of $3.9 million in the Mondays trading session. The trading value on downticks was comparatively at $2.75 million and the uptick to downtick ratio of 1.42 indicates continuous buying by the bulls. The net money flow into the stock was $1.15 million. Upticks saw transactions worth $1.51 clearly indicating buying by large investors. The total money flow for block trades stood at $1.51 million, which is a positive for the stock in the long-term. Zimmer Biomet Holdings (ZBH) fell $0.22 during the day at $125.2, a drop of -0.18% over the previous days close. However, for the week, the stock is 0.25%, compared to the previous week.
Zimmer Biomet Holdings, Inc. is up 10.09% in the last 3-month period. Year-to-Date the stock performance stands at 22.2%. Zimmer Biomet Holdings, Inc. has dropped 0.21% in the last five trading days, however, the shares have posted positive gains of 7.17% in the last 4 weeks. In a related news, Florin Daniel P, officer (Sr. VP, CFO) of Zimmer Biomet Holdings, Inc., unloaded 15,000 shares at an average price of $124.98 on July 8, 2016. The total amount of the transaction was worth $1,874,700, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Zimmer Biomet Holdings (NYSE:ZBH): On Mondays trading session , Opening price of the stock was $125.26 with an intraday high of $126.079. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $124.54. However, the stock managed to close at $124.82, a loss of 0.48% for the day. On the previous day, the stock had closed at $125.42. The total traded volume of the day was 1,181,455 shares.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.